New cream shows promise for vitiligo in Mid-Stage trial
NCT ID NCT06790862
First seen Jan 19, 2026 · Last updated Apr 30, 2026 · Updated 14 times
Summary
This study tests an experimental cream called SHR0302Base in 155 adults with nonsegmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the cream can safely restore color, especially on the face and neck, compared to a cream without the active ingredient. Participants must have stable vitiligo for at least 3 months before joining.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dermatology Hospital affiliated to Shandong First Medical University
Jinan, Shandong, 250022, China
Conditions
Explore the condition pages connected to this study.